The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication

Clinical trial NCT04800692 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04800692
Sponsor: Louis Messina
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Claudication, Intermittent Peripheral Artery Disease Peripheral Vascular Diseases

Start date: 2021-06-15
Primary completion: 2027-07-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.